XBI logo

SPDR S&P Biotech ETF (XBI)

$145.28

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on XBI

AUM

$9.94B

P/E ratio

20

Dividend yield

0.3492%

Expense ratio

0.35%

Beta

0.86596

Price on XBI

Previous close

$145.88

Today's open

$147.07

Day's range

$143.24 - $147.72

52 week range

$113.06 - $169.89

Profile about XBI

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

XBI industries and sectors

Industries

Health

Top holdings in XBI
News on XBI

Decoding Healthcare ETFs: Different Sectors, Different Strategies

While State Street SPDR S&P Biotech ETF delivered a higher 1-year total return, the Invesco fund has experienced significantly shallower drawdowns and stronger cumulative growth over the past five years. The Invesco fund offers a slightly higher dividend yield, though the State Street fund remains the larger and more cost-efficient option for investors seeking targeted industry exposure.

news source

The Motley Fool • Nov 7, 2026

news preview

IYH and XBI: Two Distinct Paths to Investing in Healthcare

iShares U.S. Healthcare ETF tracks a broad mix of pharmaceutical and medical device companies, while State Street SPDR S&P Biotech ETF focuses strictly on the biotechnology sub-industry. State Street SPDR S&P Biotech ETF has delivered a higher 1-year total return but experienced a significantly deeper maximum drawdown of 53.2%.

news source

The Motley Fool • Nov 7, 2026

news preview

Democrats Sweep Midterms: What It Means For Pharma And Biotech Holdings (Stocks To Watch)

U.S. midterm results signal a "Blue Wave," with Democrats controlling both House and Senate, likely impacting healthcare policy and funding. Health insurers like UnitedHealth and CVS Health typically rebound after policy shocks; Oscar Health stands out for ACA-driven growth and innovation.

news source

Seeking Alpha • Nov 5, 2026

news preview

Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge

Tempus AI (NASDAQ:TEM | TEM Price Prediction) was trading higher this afternoon. It sat at $80.31, up 11.21% after the precision medicine company reported third-quarter results before the open.

news source

24/7 Wall Street • Nov 2, 2026

news preview

Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs

Regeneron (NASDAQ:REGN | REGN Price Prediction) shares rose 13.55% in Friday's session, trading at $929.69 as of 9:45 AM ET on Oct 30, 2026. For a biotech worth roughly $94.

news source

24/7 Wall Street • Oct 30, 2026

news preview

ETFs That You May Consider Amid a Strengthening Biotech Outlook

Drug innovation, AI and rising M&A activity are boosting biotech optimism. Discover ETFs offering exposure to the sector.

news source

Zacks Investment Research • Oct 28, 2026

news preview

Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the State Street SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on January 31, 2006.

news source

Zacks Investment Research • Oct 26, 2026

news preview

Why $55 Million Flowed Into a Triple-Leveraged Biotech ETF Worth Less Than $600 Million

Traders poured tens of millions into a triple-leveraged biotech fund in a single day, a move that looks like bold conviction until you see what that same bet returned over five years.

news source

24/7 Wall Street • Oct 20, 2026

news preview

Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets

Shares of AbbVie, Eli Lilly and Gilead Sciences are trading at or near record highs.

news source

Market Watch • Oct 15, 2026

news preview

From Laggard to Leader: The Surprising Comeback of Healthcare

Healthcare stocks have finally stepped back into the spotlight. After spending much of the past several years in the shadow of technology and AI, the sector has quietly emerged as one of the year's more compelling comeback stories.

news source

ETF Trends • Oct 13, 2026

news preview

¹ Disclosures

Get started with M1

Invest in SPDR S&P Biotech ETF

Open an M1 investment account to buy and sell SPDR S&P Biotech ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in XBI on M1